AGP Executive Report
Last update: 9 hours agoAI Diagnostics in Cancer Care: AstraZeneca and Roche Diagnostics will expand AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets, including Taiwan, aiming to improve HER2 and TROP2 assessment and better match patients to targeted therapies. Ebola Border Measures: Taiwan will bar entry for 90 days to citizens from the DRC and Uganda starting June 2, with limited exceptions, as cases and deaths rise and the CDC cites heightened risk. Hearing Health in a Super-Aged Society: Taiwan reports a 17% rise in age-related hearing loss over five years, with 160,643 elderly people identified as having hearing impairment last year—experts warn many more may be affected but don’t seek care. Digital Health Tech in Taiwan’s Orbit: Synology launched an enterprise all-flash NVMe storage platform (PAS7700) in the Philippines, designed for AI and mission-critical workloads, reflecting the region’s push to scale data infrastructure for healthcare and research. Local Health Diplomacy: Saint Vincent and the Grenadines’ new ambassador presented credentials in Taiwan, highlighting cooperation in smart healthcare and support for Taiwan’s participation in the World Health Assembly. Healthcare Access via Trade: The U.S. and Taiwan finalized a Section 232 tariff cap at 15% for certain Taiwan imports, while noting generic pharma ingredients were not covered in the latest adjustment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.